Browse Articles

Filter By:

  • Here, the authors discuss evidence for the involvement of the cerebellum in Parkinson disease. They cover the anatomical connections between the cerebellum and basal ganglia and how functional and connectivity alterations observed in the cerebellum of people with the disease relate to specific clinical symptoms.

    • Tianbai Li
    • Weidong Le
    • Joseph Jankovic
    Review Article
  • A new study indicates that although men and women are equally likely to experience cognitive impairment after acute ischaemic stroke, there are sex differences in particular cognitive domains. Whether these differences are directly linked to biological sex is uncertain, as many factors, including age and pre-stroke factors, could contribute to cognitive outcomes.

    • Louise D. McCullough
    News & Views
  • The amyotrophic lateral sclerosis exposome is the lifetime accumulation of environmental exposures that increase disease risk and affect progression. This Review summarizes the literature that has sought to characterize aspects of the amyotrophic lateral sclerosis exposome and considers potential mechanisms of exposure-induced toxicity.

    • Stephen A. Goutman
    • Masha G. Savelieff
    • Eva L. Feldman
    Review Article
  • The TRACK-TBI LONG study has shown that outcomes are highly variable in the 7 years after traumatic brain injury (TBI). Although many patients remain stable, almost one-third experience declines in cognitive, psychiatric and functional state. These findings suggest that TBI is a chronic disease and that its management should change accordingly.

    • David J. Sharp
    • Neil S. N. Graham
    News & Views
  • Endemic parkinsonism occurs only in specific locations or populations. Here, Menšíková et al. describe clusters of endemic parkinsonism and highlight that those linked to neurotoxic environmental factors seem to be disappearing, while genetically determined clusters persist.

    • Katerina Menšíková
    • John C. Steele
    • Petr Kaňovský
    Review Article
  • Two recent studies leverage the same French population-based disease registry to describe real-world medication prescription patterns, patient characteristics and treatment effectiveness in people with schizophrenia. These studies also identify disparities in the health care and outcomes of these individuals compared with those of the general population.

    • Marco Solmi
    • Christoph U. Correll
    News & Views
  • Results from the phase III trials of the amyloid-targeting antibodies donanemab and solanezumab add further evidence that amyloid pathology is a key driver of cognitive decline in Alzheimer disease. The mixed results highlight important considerations for future trials and clinical practice.

    • Wiesje M. van der Flier
    • Betty M. Tijms
    News & Views
  • Cholesterol has diverse roles in the brain, and precise regulation of cholesterol production and catabolism is essential for healthy brain function. This Review summarizes cholesterol regulation and function in the brain and discusses evidence of cholesterol dyshomeostasis in age-related neuropathology and a number of neurological diseases. In particular, the authors focus on Huntington disease and insights from rodent models.

    • Marta Valenza
    • Giulia Birolini
    • Elena Cattaneo
    Review Article
  • Two new studies have provided important mechanistic insights into TDP-43 pathology, a hallmark of neurodegenerative conditions such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

    • Heather Wood
    Research Highlight
  • Understanding of the psychiatric and behavioural consequences of traumatic brain injury (TBI) remains limited. In this Review, Li and colleagues highlight ways to progress research in this field and discuss neuropsychiatric sequelae of TBI that affect long-term health outcomes and functional recovery.

    • Lucia M. Li
    • Alan Carson
    • Kristen Dams-O’Connor
    Review Article
  • Two studies have confirmed previous observations that an inverse relationship exists between chronological age and focal white-matter inflammatory activity in individuals with multiple sclerosis, which could underlie the relative ineffectiveness of traditional disease-modifying therapies in older individuals.

    • Benjamin M. Segal
    News & Views
  • Limbic-predominant age-related TDP43 encephalopathy (LATE) is a clinical entity characterized by amnestic dementia resembling Alzheimer disease. This Review focuses on the pathology, genetic risk factors and clinical features associated with pure LATE neuropathological change and LATE neuropathological change with coexisting pathologies.

    • Sukriti Nag
    • Julie A. Schneider
    Review Article